Results of a First-Line Study of Pembrolizumab in Advanced Urothelial Cancer
October 25th 2016Arjun Balar, MD, assistant professor of medicine, Division of Hematology & Oncology, New York University Cancer Institute, NYU Langone Medical Center, discusses the results of a recent first-line study of pembrolizumab in advanced urothelial cancer.
Watch
Findings of a Study With a Novel Antibody-Drug Conjugate in Ovarian Cancer
October 24th 2016Jasgit Sachdev, MD, clinical associate professor at Translational Genomics Research Institute, discusses a recent study of novel antibody-drug conjugate targeting protein tyrosine kinase 7 (PTK7) in ovarian cancer.
Watch
Considerations When Treating Breast Cancer in Patients of Different Ethnic Backgrounds
October 20th 2016Meena Savur Moran, MD, radiation oncologist, professor, Therapeutic Radiology, director, Breast Cancer Radiotherapy Program, Yale Cancer Center, discusses considerations oncologists take when treating patients with breast cancer of different ethnic backgrounds.
Watch
Findings of a Study Comparing Standard Radiation to IMRT in Endometrial, Cervical Cancer
October 19th 2016Ann H. Klopp, MD, PhD, discusses the results of a recent trial comparing standard radiation to intensity-modulated radiation therapy (IMRT) in endometrial and cervical cancer, and what impact these results will have.
Watch